Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 2

1(12.5%)

8Total

N/A(7)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01414647Not ApplicableCompleted

The Health Effect of Diet Rich in Nordic Berries

Role: lead

NCT01580150Not ApplicableCompleted

Effects of Berries on Post-meal Blood Sugar

Role: lead

NCT00992641Not ApplicableCompleted

The Effect of Nordic Recommended Diet on the Features of Metabolic Syndrome - Multicentre Study

Role: lead

NCT00698256Not ApplicableCompleted

Effect of High Stanol Ester Dose on Serum Lipids, Carotenoids and Fat-soluble Vitamins

Role: lead

NCT01274091Not ApplicableCompleted

Gene - Diet Interactions

Role: lead

NCT01205308Not ApplicableCompleted

Plant Stanols and Type 1 Diabetes

Role: lead

NCT00621205Not ApplicableCompleted

Gene Expression in Obesity and Insulin Resistance

Role: lead

NCT00573781Phase 2Completed

Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose Metabolism

Role: lead

All 8 trials loaded